SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-23-169053
Filing Date
2023-06-16
Accepted
2023-06-16 16:37:49
Documents
8

Document Format Files

Seq Description Document Type Size
1 425 d523313d425.htm 425 23948
2 GRAPHIC g523313g0616211511675.jpg GRAPHIC 3605
3 GRAPHIC g523313g0616211511871.jpg GRAPHIC 940
4 GRAPHIC g523313g0616211511974.jpg GRAPHIC 890
5 GRAPHIC g523313g0616211512082.jpg GRAPHIC 941
6 GRAPHIC g523313g0616211512193.jpg GRAPHIC 923
7 GRAPHIC g523313g0616211512308.jpg GRAPHIC 923
8 GRAPHIC g523313g0616211512511.jpg GRAPHIC 982
  Complete submission text file 0001193125-23-169053.txt   39337
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filed by) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Subject) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-38459 | Film No.: 231021815
SIC: 2836 Biological Products, (No Diagnostic Substances)